Use of fosfluridine tidoxil (FT) for the treatment of intraepithelial proliferative diseases

Details for Australian Patent Application No. 2007271980 (hide)

Owner Heidelberg Pharma AG

Inventors Bohm, Erwin; Stockfleth, Eggert; Kulke, Michael

Agent Griffith Hack

Pub. Number AU-A-2007271980

PCT Pub. Number WO2008/006511

Priority 11/486,376 14.07.06 US

Filing date 6 July 2007

Wipo publication date 17 January 2008

International Classifications

A61K 31/513 (2006.01) - having oxo groups directly attached to the heterocyclic ring, e.g. cytosine

A61K 31/661 (2006.01) - Phosphorus acids or esters thereof not having PC bonds, e.g. fosfosal, dichlorvos, malathion

A61P 35/00 (2006.01) Antineoplastic agents

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

Event Publications

15 January 2009 PCT application entered the National Phase

  PCT publication WO2008/006511 Priority application(s): WO2008/006511

19 February 2009 Corrigenda

  PCT applications that have entered the National Phase - Name Index Under the name Heidelberg Pharma AG, Application No. 2007271980, under INID(54) amend the title to read Use of Fosfluridine Tidoxil (FT) for the treatment of intraepithelial proliferative diseases

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007271985-Active ingredient combinations with insecticidal and acaricidal properties

2007271964-Pyrimidine derivatives as ALK-5 inhibitors